March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Virulence factors in Pseudomonas aeruginosa keratitis
Author Affiliations & Notes
  • Henri Sueke
    Ophthalmology,
    Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Jayendra Shankar
    Microbiology,
    Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Timothy Neal
    Microbiology,
    Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Sarah Aldwinckle
    Ophthalmology,
    Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Craig Winstanley
    Microbiology, University of Liverpool, Liverpool, United Kingdom
  • Stephen Tuft
    Ophthalmology, Moorfields Eye Hospital, London, United Kingdom
  • Stephen B. Kaye
    Ophthalmology,
    Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Microbiology Ophthalmic Group
    Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Footnotes
    Commercial Relationships  Henri Sueke, None; Jayendra Shankar, None; Timothy Neal, None; Sarah Aldwinckle, None; Craig Winstanley, None; Stephen Tuft, None; Stephen B. Kaye, None
  • Footnotes
    Support  Foundation for the prevention of blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6133. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Henri Sueke, Jayendra Shankar, Timothy Neal, Sarah Aldwinckle, Craig Winstanley, Stephen Tuft, Stephen B. Kaye, Microbiology Ophthalmic Group; Virulence factors in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6133.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To identify virulence factors in cases of P. aeruginosa keratitis that can be used for prognosis and personalising treatments.

 
Methods:
 

Clinical outcome data and isolates were collected from cases of P. aeruginosa keratitis from six centres around the UK from two time periods, 2003-4 and 2009-10. Isolates were genotyped utilising a novel array tube system to generate a clone type. Presence of genes coding specific exotoxin production (exoS or exoU) as well as clonal type clustering was investigated in the two time periods. Population genomic analysis between groups of isolates with related genotypes was performed using eBurst software. An association was then sought between clonal type, the presence and type of exotoxin and clinical outcome.

 
Results:
 

123 cases of P. aeruginosa keratitis over the two time periods were included. 75% and 82% of keratitis isolates respectively fell into one main cluster in the eBurst analysis, compared to 40% of non-keratitis isolates (see Figure). Exotoxin gene type (exoS or exoU) clustered with clonal type. Clinical outcome data available from 41 out of 123 isolates showed clone A, serotype O11 and the presence of exoS were was associated with larger corneal ulcers, prolonged healing time and gentamicin resistance.

 
Conclusions:
 

The identification of clonal type and the virulence factor exoS are of prognostic significance. The presence of these factors in patients with P. aeruginosa keratitis may help target treatment and potential future therapies.  

 
Keywords: pseudomonas • keratitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×